Skip to content

Amarin Pharma Inc. v. International Trade Commission

Petition for certiorari denied on December 9, 2019

Docket No. Argument Opinion Vote Author Term
19-152 N/A N/A N/A N/A OT 2019

Issue: Whether, when a manufacturer files a Lanham Act claim under the Tariff Act for competitive injuries caused by unfair trade practices, the claim is barred as a matter of law when the International Trade Commission would need to consider the meaning of terms used in the Food, Drug and Cosmetic Act in order to determine whether the claim has merit.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
07/30/2019Petition for a writ of certiorari filed. (Response due September 3, 2019)
08/27/2019Motion of International Trade Commission, et al. for an extension of time not accepted for filing. (August 28, 2019 - Corrected motion to be filed)
08/28/2019Motion to extend the time to file a response from September 3, 2019 to October 3, 2019, submitted to The Clerk.
08/30/2019Motion to extend the time to file a response is granted and the time is extended to and including October 3, 2019, for all respondents.
09/30/2019Motion to extend the time to file a response from October 3, 2019 to November 4, 2019, submitted to The Clerk.
10/02/2019Motion to extend the time to file a response is granted and the time is further extended to and including November 4, 2019, for all respondents.
10/22/2019Letter of October 22, 2019 from counsel for petitioners filed.
11/04/2019Brief of respondents International Trade Commission, et al. in opposition filed.
11/04/2019Brief of respondents Royal DSM NV, et al. in opposition filed.
11/18/2019Reply of petitioners Amarin Pharma, Inc., et al. filed.
11/20/2019DISTRIBUTED for Conference of 12/6/2019.
12/09/2019Petition DENIED.